UBS O'Connor’s Jackson Acquisition Company Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 RJAC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-304,973
Closed -$37K 768
2022
Q3
$37K Sell
304,973
-30,530
-9% -$3.82K ﹤0.01% 867
2022
Q2
$55K Buy
+335,503
New +$62.2K ﹤0.01% 865

Other funds holding RJAC.WS

UBS O'Connor's RJAC.WS Position: Q4 2022 in Review

UBS O'Connor sold out of Jackson Acquisition Company Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (RJAC.WS) in Q4 2022, closing a stake of 304,973 shares — an estimated $37K sold.

UBS O'Connor first reported a position in RJAC.WS in Q2 2022 and held it in 2 quarters. The position peaked at $55K in Q2 2022. 38 funds tracked by Wall St. Rank hold RJAC.WS as of Q4 2022.

  • UBS O'Connor reported no remaining Jackson Acquisition Company Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • UBS O'Connor sold 304,973 Jackson Acquisition Company Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 shares in Q4 2022, an estimated $37K.
  • UBS O'Connor first reported a position in Jackson Acquisition Company Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in Q2 2022 and held it in 2 quarters.
  • UBS O'Connor's Jackson Acquisition Company Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position peaked at $55K in Q2 2022.
  • 38 funds tracked by Wall St. Rank held Jackson Acquisition Company Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.